Employee wellness programs are ubiquitous. The promise of healthier employees, improved productivity, and long-term cost savings make these programs an expectation, not an exception.
However, as health care costs rise, especially in relation to high-visibility treatments like GLP-1 medications, many HR leaders are asking the critical question: Are our wellness programs simply "checking a box," or are they truly designed to help employees live healthier lives and stay well?
There is a well-documented gap between the intention of wellness programs and their real-world impact, particularly when it comes to diabetes care and weight management. But stepping away from an app-based program and leaning into a more personalized model can allow employers to recalibrate their wellness strategies and finally achieve measurable outcomes for their workforce.
Today's wellness programs have their limits
Point-based tracking systems, wellness apps, or self-guided education modules are all common and convenient tools offered by employers. But the data shows that, often, these do not translate into meaningful health or lifestyle changes. Whether employees are logging steps, clicking through or self-reporting behaviors, employers frequently assume that participation and "checking the box" equals progress.
Meanwhile, the reality is that conditions like diabetes, cardiovascular disease, obesity, and sleep apnea continue to rise.
Now that obesity is formally recognized as a chronic disease by leading organizations, including the American Medical Association (AMA), World Health Organization (WHO), and National Institutes of Health (NIH), human resources teams can use this moment to reevaluate where their wellness dollars are going. If an incentive program only motivates employees to "check in" without changing behavior, return on investment will continue to fall short.
Healthier employees lead to higher productivity, better retention, and lower long-term cost of care. But achieving these goals requires more than just apps. It requires support that meets employees where they are.
Big investment, uneven returns: GLP-1 coverage
GLP-1 medications, such as semaglutide and tirzepatide, have transformed the treatment landscape for Type 2 diabetes and obesity. They are also being studied for everything from cardiovascular disease and sleep apnea to substance use disorders.
While GLP-1s are powerful, they are not magic bullets, and they are costly. In 2025, the majority of mid- to large-sized companies in the U.S. cover GLP-1s for diabetes, while fewer employers offer coverage for weight loss.
Because GLP-1 coverage represents a significant investment for employers, maximizing their full potential is essential. Employees taking GLP-1s often face challenges with medication adherence, whether from managing side effects or navigating necessary lifestyle changes. When employers pair GLP-1 coverage with wraparound services like nutrition guidance, symptom management, and behavioral coaching, they remove key barriers to success and enable sustained, meaningful results.
This comprehensive approach helps employers build a healthier, more productive workforce while realizing strong returns on their investment in employee wellbeing.
Should employers broaden GLP-1 coverage?
Because GLP-1 medications have both proven uses and significant future potential, employers should carefully consider whether to provide coverage for these drugs. Coverage is most effective when employers also invest in the surrounding care that make these medications work.
When employees experience safe and sustainable weight loss and consistent management of chronic conditions like diabetes, employers benefit through:
- Lowered risk of chronic diseases
- Fewer acute care events
- Improved cardiovascular outcomes
- Reduced need for other high-cost medications
- Higher workplace engagement and productivity
With GLP-1s, as with any new medications or procedures, coverage decisions shouldn't be made in isolation; they should be part of a long-term health strategy.
Integrating comprehensive GLP-1 management into your benefits plan
To get meaningful and more sustainable results from GLP-1 coverage, employers should consider pairing medication benefits with individualized support. The most successful programs include:
- One-on-one coaching with pharmacists and dieticians: This offers the personalized support employees need to understand their lifestyle stressors, unique barriers, how to manage side effects, and more. This can mean the difference between employees quitting the medications after a short period of time versus reaching their maintenance doses and long-term goals.
- At least six to 12 months of structured, professionally guided care: This allows time for positive habits to form, sustainable behavior changes, longer-term goals such as stress management and nutrition, and even potentially medication off ramping, when clinically appropriate. This type of integrated model brings wellness programs back to what they were meant to be: supportive, measurable, human, and effective.
- Workplace culture that supports healthier choices: Messages can become muddled when employers cover GLP-1s but offer donuts and cookies during every meeting. Wellness needs to be reinforced throughout the workplace environment.
What does success look like?
Success in a GLP-1-inclusive wellness program goes beyond prescriptions filled and weight lost. Key metrics to include are:
- Medication adherence
- Clinical outcomes including lowering A1c, reducing blood pressure and weight, improving sleep apnea, and reducing medication dependence
- Program engagement and active participation instead of passively clicking an app
- Quality of life improvements in mental health, mobility, and productivity
- Reduced waste in prescription benefit dollars
- Lower long-term costs associated with preventable chronic disease
A forward-thinking approach: GLP-1s beyond diabetes and obesity
GLP-1s are being studied for a wide range of conditions, including Parkinson's diseases, gastrointestinal disorders, psychiatric conditions, substance use disorders – to name a few.
Forward-thinking employers should be planning for expanded GLP-1 coverage now rather than reacting later. For example, if GLP-1s receive approval for addiction treatment, mental health parity laws may require most plans to cover them.
Therefore, budgeting for expanded indications over the next 3-5 years is a good financial and HR strategy. Additionally, employees are increasingly evaluating benefits packages when comparing employers, and GLP-1 coverage is becoming a visible differentiator.
GLP-1s can transform employee health when done in a strategic and thoughtful way. By taking a whole-person approach and supporting employees with comprehensive, individualized care, employers are far more likely to see meaningful, lasting results that benefit both the individual and the organization. For HR leaders, the opportunity is clear: move away from check-the-box wellness apps to programs that improve lives and deliver measurable business impact.
Employees want support while employers need results. Pharmacist-led, holistic programs can deliver both and they represent the future of meaningful workplace wellness.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.